Press release
United States Cellulite Treatment Market 2025: Industry Developments, Future Growth, Share & Industry Insights | Endo Aesthetics, Candela Corporation, Cynosure, Cutera Inc, Zimmer Aesthetics
Cellulite Treatment Market - DataM Intelligence
Get a Free Sample Research PDF: https://www.datamintelligence.com/download-sample/cellulite-treatment-market?sg
USA - Industry Latest News 2025:
✅ 05 Nov 2025 - Merz Aesthetics: FDA clearance of Ultherapy PRIME for new body areas (arms, abdomen) - expansion of a non-invasive skin-tightening platform relevant to body/anti-cellulite treatment strategies.
✅ 24 Apr 2025 - Candela: launched the Vbeam Pro laser platform (announced at 2025 meetings) - new energy-based device widely promoted for dermatologic & body indications.
Europe - Industry Latest News 2025:
✅ 24 Jan 2025 - Allergan Aesthetics (AbbVie) unveiled the AA Signature multimodal program at IMCAS 2025 (Paris) - part of European commercialization and treatment-protocol activity that touches body/skin-quality management used alongside cellulite therapies.
✅ 14 Aug 2024 → Apr 2025 rollout - Candela announced FDA/market launches of new platforms (Vbeam Pro shown at 2025 meetings) with European exhibition presence and product promotion across EMEA in 2025.
Buy Now & Get 30% OFF - (Grab 50% OFF on 2+ reports): https://www.datamintelligence.com/buy-now-page?report=cellulite-treatment-market?sg
Market Geographical Share:
• North America holds a significant share of the global cellulite treatment market, primarily due to high consumer spending on cosmetic procedures and the presence of advanced dermatology and aesthetic centers. The United States dominates this region, driven by the popularity of non-surgical treatments such as laser therapy, radiofrequency, and acoustic wave therapy. Growing acceptance of body contouring among both men and women further contributes to regional growth.
• Europe represents the second-largest market, supported by well-established healthcare infrastructure and a strong demand for aesthetic procedures across countries such as Germany, France, Italy, and the UK. The region also benefits from an aging population seeking anti-aging and skin-tightening solutions. The increasing availability of FDA- and CE-approved cellulite reduction technologies boosts adoption across medical spas and clinics.
Market Drivers
1. Rising Aesthetic Awareness: Increasing social media influence and changing beauty standards are encouraging consumers to invest in body contouring and skin-smoothing procedures.
2. Technological Advancements: The introduction of minimally invasive and non-invasive treatment options such as laser-assisted therapy, cryolipolysis, and radiofrequency enhances treatment safety, comfort, and efficacy.
3. Growing Medical Spa Industry: Expansion of medical spas and dermatology clinics offering combination therapies for cellulite reduction boosts market penetration.
4. Increased Female Workforce Participation: Higher disposable income among working women is accelerating spending on aesthetic treatments.
Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/cellulite-treatment-market?sg
By Procedure
Non-Invasive (largest segment today)
• Market position: non-invasive procedures (radiofrequency, ultrasound, acoustic wave, lasers, cryolipolysis-style body-contouring adjuncts) lead revenue in most reports and account for the single largest share of current market value. Typical reported shares cluster around ~35-50% of the procedure mix.
Minimally Invasive (fastest growth potential)
• Market position: smaller than non-invasive today but often reported as the fastest-growing procedure category as new targeted techniques and injectables enter/exit market. Conservatively estimate ~25-35% of procedure revenue in many market splits.
Topical (supplements & creams; lowest revenue per patient)
• Market position: topical treatments (creams, serums, OTC actives and cosmeceuticals) represent a meaningful but smaller revenue slice - ~10-25% depending on whether reports include retail OTC sales alongside clinical procedures.
By Cellulite Type
• Soft Cellulite (market leader)
Share: most reports show soft cellulite as the largest patient/volume segment roughly ~45-52% of cases treated commercially (patients seeking treatment and procedure selection skew to soft type).
• Hard Cellulite
Share: typically the second-largest slice - ~25-35%. Treatments often trend toward more aggressive/minimally invasive options because of firmness and tethering.
• Edematous Cellulite
Smallest commercial share ~10-20%. Management often combines lymphatic/medical approaches plus procedures; market spend per patient can be variable.
Get 2-Day Free Trial + 50% OFF DataM Subscription@ https://www.datamintelligence.com/reports-subscription?sg
Key Market Players:
Key players are Merz Pharma GmbH & Co KgaA, Inceler Medikal Co Ltd, Candela Corporation, Cynosure, Cutera Inc, Zimmer Aesthetics, Cymedics GmbH & Co KG, Beijing Nubway S&T Co Ltd, Endo Aesthetics LLC.
• Merz Pharma GmbH & Co KGaA - Merz (Merz Aesthetics) is a long-standing global aesthetics company with injectables and device portfolios (Cellfina historically for cellulite, plus other aesthetic products); it's an established brand in physician-led aesthetic markets and a notable top-tier competitor in procedures that target cellulite/skin laxity.
• İnceler Medikal Co Ltd - Turkish manufacturer known for ESWT (shockwave) and energy-based devices used in dermatology and orthopedics; shockwave therapy is used by some clinics as a non-invasive option to improve cellulite/skin texture, so İnceler plays a niche/regional device role rather than global premium market share.
• Candela Corporation - Global laser/IPL device leader with body-contouring and skin-tightening products (e.g., VelaShape-type platforms historically); strong distributor network and clinical adoption gives Candela a meaningful share among device providers in non-invasive cellulite solutions.
• Cynosure - Major aesthetic device OEM (SculpSure and other body-contouring systems). SculpSure and related platforms are commonly used in clinics for adipose reduction and skin contouring positioning Cynosure as a leading device provider in the non-invasive segment.
• Cutera, Inc. - Offers a range of body-contouring solutions (truSculpt family) and has clinical adoption for temporary cellulite reduction / subcutaneous fat reduction; another important global device competitor in the non-invasive market segment.
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Cellulite Treatment Market 2025: Industry Developments, Future Growth, Share & Industry Insights | Endo Aesthetics, Candela Corporation, Cynosure, Cutera Inc, Zimmer Aesthetics here
News-ID: 4259091 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
AI-Enhanced Electronic Health Records Market to Reach US$ 52.50 Billion by 2033 …
The AI-Enhanced Electronic Health Records (EHR) Market reached US$ 6.57 billion in 2024 and is expected to reach US$ 52.50 billion by 2033, growing at a CAGR of 26.2% during the forecast period 2025-2033. The market has demonstrated strong momentum, increasing from US$ 3.64 billion in 2022 to US$ 4.18 billion in 2023, reflecting rapid adoption of AI-driven digital health solutions across healthcare systems worldwide.
AI enhances EHR platforms through advanced…
Nasal Drug Delivery Technology Market to Reach US$ 136.97 Billion by 2033 at 6.7 …
The Nasal Drug Delivery Technology Market reached US$ 81.69 billion in 2024 and is expected to reach US$ 136.97 billion by 2033, growing at a CAGR of 6.7% during the forecast period 2025-2033. The market is witnessing steady growth driven by increasing demand for non-invasive drug administration routes, rising prevalence of chronic and respiratory diseases, and growing adoption of patient-friendly drug delivery systems.
Nasal drug delivery technology involves administering therapeutics through…
Serverless Computing Market Set for Strong Growth to USD 40.9 Billion by 2031, L …
The Global Serverless Computing Market reached USD 9.3 billion in 2023 and is expected to reach USD 40.9 billion by 2031, growing at a strong CAGR of 20.6% during the forecast period 2024-2031.
Market growth is driven by increasing adoption of cloud-native architectures, rising demand for scalable and cost-efficient application development, and growing use of microservices across enterprises. Additionally, rapid digital transformation, expansion of DevOps practices, and increased adoption of serverless…
Heart Valve Devices Market to Reach US$ 34.6 Billion by 2033 at 12.34% CAGR; Nor …
The Heart Valve Devices Market reached US$ 12.76 billion in 2024 and is expected to reach US$ 34.6 billion by 2033, growing at a CAGR of 12.34% during the forecast period 2025-2033. The market is experiencing strong growth driven by the rising prevalence of valvular heart diseases, increasing geriatric population, and growing adoption of minimally invasive and transcatheter valve replacement procedures.
Heart valve devices include mechanical valves, bioprosthetic valves, and transcatheter…
More Releases for Cellulite
Key Trends Reshaping the Cellulite Treatment Market: Transformative Products Red …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Cellulite Treatment Market Size Growth Forecast: What to Expect by 2025?
The overall valuation of the cellulite management industry has experienced swift expansion lately, set to increase from its 2024 figure of $2.26 billion to $2.51 billion in 2025, reflecting a compound annual growth rate (CAGR) of 10.7%; this…
Global Cellulite Treatment Market: A Growing Opportunity
The global cellulite treatment market has seen remarkable growth, with the market size reaching $2.1 billion in 2021 and projected to expand to $5.7 billion by 2031, representing a compound annual growth rate (CAGR) of 10.3%. Below are key insights driving this market expansion:
𝐆𝐞𝐭 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresearch.com/request-sample/A10923
Overview of Cellulite and Its Treatment
• Cellulite: A harmless yet common skin condition that leads to a lumpy and dimpled appearance,…
Europe Cellulite Treatment Market Growth, Size 2023-2032
According to Inkwood Research, the Europe cellulite treatment market is on a robust growth trajectory and is projected to expand at a compound annual growth rate (CAGR) of 9.47% during the forecast period from 2023 to 2032. By the end of this period, the market is expected to achieve a revenue share of approximately $1263.03 million.
This growth is significantly influenced by the presence of major companies such as Johnson &…
Experience the Effectiveness of Cellulite Reduction Treatment | REVMED
REVMED is a biotechnology company with the zero contamination technology to isolate and concentrate stem cells from the body's blood, bone marrow, and fat. It strives to open a new chapter in effective and safe stem cell therapy and enhance Korea's technological competitiveness in the global market. In the biotech field, one must be prepared to commit for at least 10 years. It requires a significant amount of patience and…
Europe Cellulite Treatment Market: Overview for 2023-2030
Based on Triton's report, the Europe cellulite treatment market is poised for robust growth, with an estimated compound annual growth rate (CAGR) of 9.51% projected from 2023 to 2030. This comprehensive market analysis encompasses key countries in the region, including the United Kingdom, Germany, France, Spain, Italy, and the Nordic Countries.
Read the Market Summary Here: https://www.tritonmarketresearch.com/reports/europe-cellulite-treatment-market#report-overview?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=TritonPR
The market is characterized by a diverse range of companies contributing to the cellulite…
ASIA-PACIFIC CELLULITE TREATMENT MARKET FORECAST 2023-2032
The Asia-Pacific Cellulite Treatment Market is poised for substantial growth, projecting an impressive Compound Annual Growth Rate (CAGR) of 9.78% during the forecasted period from 2023 to 2032. This robust expansion is anticipated to result in a significant revenue share of $1,205.49 million by 2032, underscoring the region's increasing focus on advanced and effective cellulite treatment solutions.
Refer to the Report Summary Here: https://inkwoodresearch.com/reports/asia-pacific-cellulite-treatment-market/?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=InkwoodPR
Major companies contributing to the Asia-Pacific…
